Genetic Risk Communication: Fresh Study Shows Effective Patient Outreach
A large-scale study demonstrates that healthcare systems can effectively and responsibly communicate genetic risk information to patients. Researchers successfully made direct contact with over 70% of individuals identified as having high genetic risk for various conditions, paving the way for broader adoption of genetic testing in healthcare.
The study, led by researchers from the University of Cincinnati and Cincinnati Children’s Hospital over six years, addresses the ethical and practical challenges of rapidly advancing genetic risk screening. It’s now possible to identify individuals predisposed to serious diseases, raising questions about how to share this information responsibly, protect patient privacy, and ensure beneficial healthcare outcomes.
Understanding Polygenic Risk Scores
The research involved approximately 24,000 participants aged 3 to 75, whose risks for 11 common diseases were assessed using polygenic risk scores. These scores estimate an individual’s likelihood of developing a disease based on their genetic makeup.
Diseases analyzed included asthma, type 1 diabetes in children, obesity, type 2 diabetes, heart disease, atrial fibrillation, chronic kidney disease, high cholesterol, colon cancer, prostate cancer, and breast cancer.
A Multi-Level Communication Approach
The study highlights the importance of a flexible communication strategy. Low-risk results were delivered through indirect methods like email or mail. However, high-risk results warranted direct, individual communication via phone, video call, or in-person meetings to ensure understanding and provide psychological support.
Results were also integrated into electronic medical records while maintaining data privacy, allowing both patients and physicians to access and discuss the information. This approach balances medical transparency with patient privacy and autonomy.
Of the approximately 5,000 cases identified as high-risk, direct communication was successfully established in about 79% of adults and 68% of children. Challenges remained in reaching all participants, limiting the overall percentage of direct contact.
When direct communication wasn’t possible, results were added to electronic medical records, with provisions for the patient and physician to contact the research team for further discussion.
Disparities in Access to Genetic Risk Information
The study revealed disparities in access to direct communication. Individuals with greater socioeconomic stability – such as higher education levels and homeownership – were more likely to complete individual communication sessions. Health insurance status also influenced access to these services.
What are Genetic Risk Tests?
Genetic Risk Tests Explained
- Analysis of genetic material through a blood or saliva sample.
- Looks for mutations or changes in genes associated with certain diseases.
- Estimates the probability of contracting a disease, but does not provide a direct diagnosis.
Types of Genetic Risk Tests:
· Prediction checks: To assess the risk of future diseases such as cancer or diabetes.
· Pregnancy examinations: To determine if an individual carries a gene that may be passed on to their children.
· Prenatal examinations: To detect genetic diseases in a fetus.
· Drug response tests: To understand how the body may respond to certain medications.
Importance of Genetic Risk Tests:
- Early detection: Helps in taking preventive measures before a disease appears.
- Personalized treatment: Enables the selection of appropriate medications and treatments.
- Family planning: Provides information about the possibility of transmitting diseases to children.
- Lifestyle modification: Supports changes in diet or exercise to reduce risk.
- Reduced complications: Through early medical follow-up.
Researchers emphasize that the study demonstrates the feasibility of large-scale genetic test result return programs. However, they also highlight the require for healthcare systems to become more adaptable and inclusive in their communication strategies to ensure equitable access to these benefits, particularly for individuals at high risk who may require early intervention, preventative care, or close monitoring.
This research supports the adoption of balanced strategies for managing genetic information, combining scientific advancements with respect for patient rights as medicine moves toward greater personalization and precision in diagnosis and treatment. Source
Related reading